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Summary
Trypanosoma brucei faces relentless immune attack
in the mammalian bloodstream, where it is protected
by an essential coat of Variant Surface Glycoprotein
(VSG) comprising 10% total protein. The active VSG
gene is in a Pol I-transcribed telomeric expression
site (ES). We investigated factors mediating these
extremely high levels of VSG expression by inserting
ectopic VSG117 into VSG221 expressing T. brucei.
Mutational analysis of the ectopic VSG 30UTR demon-
strated the essentiality of a conserved 16-mer for
mRNA stability. Expressing ectopic VSG117 from dif-
ferent genomic locations showed that functional VSG
levels could be produced from a gene 60 kb upstream
of its normal telomeric location. High, but very heter-
ogeneous levels of VSG117 were obtained from the
Pol I-transcribed rDNA. Blocking VSG synthesis nor-
mally triggers a precise precytokinesis cell-cycle
checkpoint. VSG117 expression from the rDNA was
not adequate for functional complementation, and
the stalled cells arrested prior to cytokinesis. How-
ever, VSG levels were not consistently low enough to
trigger a characteristic ‘VSG synthesis block’ cell-
cycle checkpoint, as some cells reinitiated S phase.
This demonstrates the essentiality of a Pol
I-transcribed ES, as well as conserved VSG 30UTR
16-mer sequences for the generation of functional
levels of VSG expression in bloodstream form T.
brucei.
Introduction
The African trypanosome Trypanosoma brucei is a para-
digm for monoallelic control and antigenic variation. T.
brucei is the causative agent of Human African Trypano-
somiasis and ‘nagana’ in livestock, which are transmit-
ted by tsetse flies. Although case numbers for
trypanosomiasis have been falling, 70 million people are
still estimated to be at potential risk of infection (Franco
et al., 2014). In addition to the human mortality, livestock
diseases caused by T. brucei and related trypanosoma-
tids cause enormous economic losses. It has been esti-
mated that eliminating these would result in a net
benefit to African countries of nearly $2.5 billion over a
20 year period (Shaw et al., 2014). T. brucei thrives in
the bloodstream of the mammalian host, despite being
exposed to continuous attack by components of the
immune system including complement and antibodies
(Rudenko, 2011; Mugnier et al., 2016). A chronic infec-
tion is maintained through a highly sophisticated strat-
egy of antigenic variation, based on the monoallelic
expression of Variant Surface Glycoprotein (VSG)
(Glover et al., 2013b; Gunzl et al., 2015; Duraisingh and
Horn, 2016).
Individual parasites are coated with a VSG coat com-
posed of a dense layer of 10 million rod-like VSG mole-
cules attached to the T. brucei cell surface via a
glycosylphosphatidylinositol (GPI) anchor (Cross, 1975;
Schwede and Carrington, 2010; Schwede et al., 2015).
VSG is the most abundant protein in bloodstream form
T. brucei making up about 10% of the total protein
(Wang et al., 2003), and is essential even in vitro. Block-
ing VSG synthesis triggers a cell-cycle checkpoint
resulting in cells stalled pre-cytokinesis which do not
undergo re-initiation of S-phase (Sheader et al., 2005;
Smith et al., 2009).
The gene for the active VSG is located in one of
about fifteen extensive (40–60 kb) telomeric VSG
expression site (ES) transcription units containing large
families of polymorphic expression site associated
genes as well as the telomeric VSG (Becker et al.,
2004; Hertz-Fowler et al., 2008). ESs are controlled in a
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strictly mono-allelic fashion (Chaves et al., 1999; Glover
et al., 2016). Although the GPI-anchored VSG protein is
highly immunogenic, stochastic VSG switch events
occur in the population, leading to the expression of
new and immunologically distinct variants. VSG switch-
ing can involve a transcriptional switch to another ES
(Alsford et al., 2012). Alternatively, movement of silent
VSGs (or segments of VSGs) into the active ES through
DNA rearrangements allows the trypanosome to switch
between different VSGs or create new ‘mosaic’ variants
(Hall et al., 2013; McCulloch et al., 2015). As T. brucei
has an extensive wardrobe of thousands of VSG genes
and pseudogenes, a chronic infection can be mounted
which can last for years (Marcello and Barry, 2007;
Cross et al., 2014; Mugnier et al., 2015).
Unusually, VSG ESs are transcribed by RNA polymer-
ase I (Pol I), which exclusively transcribes ribosomal
DNA (rDNA) in other eukaryotes (Gunzl et al., 2003).
The active ES is located in a non-nucleolar location
known as the Expression Site Body (ESB) (Navarro and
Gull, 2001). The ESB is formed around a transcription-
ally active ES (Kerry et al., 2017), and presumably con-
tains the transcription and RNA processing machinery
necessary for the production of very high levels of VSG
transcript. T. brucei is the only eukaryote known to be
capable of utilising Pol I to transcribe protein coding
genes, including those encoded in ESs as well as procy-
clin (major surface protein of procyclic T. brucei) (Roditi
et al., 1998; Gunzl et al., 2003). This unusual ability is
presumably possible because trans-splicing adds a
capped Pol II-derived spliced leader RNA to the Pol I-
derived transcript which would otherwise be uncapped,
and, therefore, untranslatable (Bruderer et al., 2003).
All other protein coding genes in T. brucei are present
in extensive polycistronic arrays which are constitutively
transcribed by Pol II (Kolev et al., 2010). There is no evi-
dence for regulated Pol II transcription, and Pol II pro-
moter elements appear to be simple G-stretches, which
are functionally defined predominantly at the epigenetic
level (Siegel et al., 2009; Wright et al., 2010). High lev-
els of gene expression in T. brucei can be a conse-
quence of gene amplification, with some particularly
abundant proteins encoded by large gene families
(Berriman et al., 2005). However, RNA levels are pre-
dominantly modulated post-transcriptionally through
RNA stability elements, allowing life-cycle specific
expression of constitutively transcribed genes (Kramer,
2012; Clayton, 2014).
For antigenic variation to work effectively, there needs
to be mono-allelic expression of a single surface antigen
type, and the major variant needs to be continuously
switched during a chronic infection. The trypanosome is,
therefore, restricted to express the vast amount of VSG
it requires from a single copy gene. We asked which
features allow the trypanosome to generate such high
levels of VSG expression from a single gene, and tested
the functionality of ectopic VSG located in different
genomic locations, and flanked downstream by different
30 untranslated regions (UTRs). We demonstrate the
essentiality of a conserved 16-mer sequence within the
VSG 30UTR for conferring functional levels of VSG
mRNA stability (Berberof et al., 1995). In addition, we
show that high levels of VSG are only expressed from
Pol I- transcribed loci, although functional levels of VSG
expression were only obtained from the Pol I-transcribed
ES. The exact location of the VSG gene within the ES
transcription unit was not critical. In contrast, the level of
VSG expression from the Pol I-transcribed rDNA loci
was heterogeneous, and did not adequately comple-
ment the cell when endogenous VSG transcript was
knocked-down using RNAi. These results highlight key
features essential for generating functional levels of
VSG expression in bloodstream form T. brucei, enabling
it to be such an effective pathogen.
Results
Functional levels of VSG can be expressed 60 kb
upstream of the ES telomere
VSG is the most abundant protein in bloodstream form
T. brucei, and a relatively minor reduction in its expres-
sion level is detrimental even in vitro in the absence of
an immune system (Sheader et al., 2005). The active
VSG is expressed from an extensive (40–60 kb) telo-
meric bloodstream form ES, where it is invariably
located adjacent to the telomere repeats (Berriman
et al., 2002; Becker et al., 2004; Hertz-Fowler et al.,
2008). We first investigated the role of genomic location
in facilitating these very high levels of VSG expression,
and determined if functional levels could be expressed
from a VSG located immediately downstream of the
active ES promoter, rather than at its normal telomeric
location 60 kb downstream.
We inserted a construct containing ectopic VSG117
immediately downstream of the active VSG221 ES pro-
moter in the T. brucei 427 ‘single-marker’ cell line
(SM221) (Fig. 1A) (Wirtz et al., 1999; Smith et al.,
2009). The resulting T. brucei SM221/117 cell line
expressed high levels of ectopic VSG117 in a back-
ground of endogenous VSG221. This resulted in a
reduction in VSG221 to approximately 50% wild type
levels. Although the relative ratios of expression of
VSG117 and VSG221 were variable, the levels
appeared inversely correlated with each other (Fig. 1B).
This pattern of an approximately inverse correlation
between the amount of ectopic VSG117 and endoge-
nous VSG221 mRNA within the cell was repeatedly
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observed throughout this study using a broad range of
different cell lines (Supporting Information Fig. S1).
The growth rate of T. brucei ‘double-expressers’
expressing two VSGs from the same ES was the same
as that of T. brucei expressing only VSG221 (Fig. 1C)
(Munoz-Jordan et al., 1996; Smith et al., 2009). Blocking
VSG synthesis with RNAi leads to an abrupt cell-cycle
arrest, which can be rescued by expression of a second
ectopic VSG from within the active ES (Smith et al.,
2009). However, as RNAi does not result in complete
removal of all targeted mRNA, we asked in a more rigor-
ous fashion if bloodstream form T. brucei could be made
fully reliant on a VSG expressed from immediately
behind the ES promoter more than 60 kb upstream of
its normal location.
We, therefore, deleted the telomeric VSG221 in these
‘double-expresser’ T. brucei and replaced it with a blasti-
cidin resistance gene (Fig. 1A). The resulting ‘single-
expresser’ T. brucei SMD221/117 cell line only
expressed VSG117 (Fig. 1B), at levels which were
Fig. 1. Functional levels of VSG
expression from a gene inserted 60 kb
upstream of the ES telomere.
A. Schematic showing the generation of
the T. brucei SM221/117 ‘double-
expresser’ cell line and the subsequent
deletion of telomeric VSG221 to
generate SMD221/117. T. brucei SM221
expresses VSG221 from the active
VSG221 ES, where the ES promoter is
indicated with a flag, relevant ES
associated genes with open boxes,
simple sequence repeats with hatched
boxes, telomere repeats with horizontal
arrows, and ES transcription with an
arrow. A construct containing VSG117
(red box) and a puromycin resistance
gene (purple box) was integrated
immediately downstream of the VSG221
ES promoter, generating SM221/117.
The VSG221 gene (green box) was
subsequently deleted and replaced with
a blasticidin resistance gene (blue box),
generating SMD221/117.
B. Western blot analysis of VSG221 and
VSG117 expression in the T. brucei
SM221/117 or SMD221/117 cell lines,
where two clones (c1 and c2) were
analysed for each. The VSGVO2
expressing cell line T. brucei HNI(VO21)
and the VSG221 expressing cell line
T. brucei BF(2211) are included as
controls, and BiP protein served as a
loading control.
C. Cumulative growth curve of the
parental T. brucei SM221 cell line, one
clone of T. brucei SM221/117 (c2), and
two clones of T. brucei SMD221/117 (c1
and c2). The mean of three replicates is
shown with standard deviation indicated
with error bars.
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increased compared with ‘double-expresser’ cells. This
indicates that a fixed maximal amount of VSG can be
stably expressed, which is also essential for trypano-
some survival. The VSG117 ‘single-expresser’ cell lines
grew slightly slower than either the single or double-
expresser parental lines (Fig. 1C). However, this could
be a consequence of slightly less optimal levels of
VSG117 expression, possibly due to suboptimal RNA
processing signals around the ectopic VSG117. As
ectopic expression of VSG117 could rescue the cell
from a precytokinesis arrest, this demonstrates that the
invariably telomeric location of VSG within the blood-
stream form ES is not essential for adequate levels of
expression.
High levels of expression of ectopic VSG117 from Pol l
transcribed loci
We next expressed ectopic VSG117 from other genomic
locations, including a tagged Pol I rDNA spacer, a Pol II-
transcribed a-b tubulin locus, or upstream of a silent Pol
I procyclin transcription unit (Fig. 2A), where constructs
integrating in the rDNA spacer or upstream of the procy-
clin genes were transcribed by an ectopic rDNA pro-
moter. Levels of ectopically expressed VSG117 were
quantified using LiCor analysis (Fig. 2B). As seen previ-
ously, expression of ectopic VSG117 in a background of
endogenous VSG221 appeared to result in a reduction
in VSG117 levels compared with VSG117 ‘single-
expresser’ T. brucei. High levels of VSG117 were
Fig. 2. High levels of VSG expression can only be obtained from Pol I transcription units.
A. Schematic showing the integration of constructs containing VSG117 (red box) and a hygromycin resistance gene (violet box) into different
genomic loci in T. brucei expressing VSG221. These include immediately downstream of the VSG221 ES promoter (white flag), within a
tagged rDNA spacer (18S and 28S rRNA genes indicated with black boxes), within the Pol II-transcribed ab tubulin array (genes indicated
with grey boxes) or upstream of the silent procyclin transcription units (hypothetical protein indicated with HyP, procyclin promoter with a grey
flag, and EP1 and EP2 procyclin genes with grey boxes). Constructs integrating into the rDNA spacer or upstream of the procyclin genes
contain an ectopic rDNA promoter (black flag) directing transcription. Transcription is indicated with arrows.
B. Levels of VSG117 expressed from ectopic loci assayed using LiCor analysis. VSG221 is expressed from the active VSG221 ES in all cell
lines except for SMD221/117. Quantification is shown below, with data presented as arbitrary units normalised to BiP. Results are from three
biological replicates, with standard deviation indicated with error bars
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expressed from either the Pol I-transcribed ES or rDNA
(at respectively 34.36 17.9% or 62.46 8.4% levels of
the VSG117 ‘single-expresser’ T. brucei SMD221/117).
In contrast, very low levels of VSG117 expression were
obtained from the Pol II a-b tubulin transcription unit
(2.96 0.7%), and negligible amounts (< 1%) were
obtained upstream of the inactive procyclin loci.
We next determined the role of the VSG 30 flanking
regions for VSG expression, and compared levels of
expression of ectopic VSG117 flanked downstream by 30
sequences from either VSG221 or a-tubulin (Fig. 3). High
levels of VSG117 expression could only be obtained if
the VSG gene was flanked downstream by a VSG 30
sequence. Replacing these 30 flanking sequences with
those from tubulin resulted in a 4–12-fold reduction in
VSG117 transcript levels (Fig. 3A). Negligible amounts of
ectopic VSG117 were expressed from either the ab-
tubulin array or upstream of the procyclin transcription
unit irrespective of the 30 flanking region. These results
were also reflected at the protein level (Fig. 3B). The
higher levels of VSG117 expression obtained from a
VSG117 gene flanked with VSG 30 sequences was a
consequence of a stabilising effect of these sequences
on the VSG transcript. VSG mRNA undergoes biphasic
RNA decay, characterised by initial slow decay followed
by a faster reduction in transcript levels (Hoek et al.,
2002; Clayton, 2014). This appears to be a general fea-
ture for T. brucei mRNAs that have long half-lives (Fadda
et al., 2014). VSG117 transcript with VSG 30 sequences
had a mRNA half-life of 88.76 22.4 min, compared with
29.76 11.4 min if these 30 sequences were replaced with
those from tubulin (Supporting Information Fig. S2). Our
estimate of a VSG mRNA half-life of between 85 and 99
min is comparable with the value of 84–90 min previously
determined using Northern blotting (Hoek et al., 2002).
We next sought to determine if the adjacent regions
downstream of the VSG had an effect on the increased
RNA stability, and found that the observed stabilising
Fig. 3. The VSG 30UTR is essential for
high levels of expression of VSG mRNA.
A. Quantification of mRNA levels
expressed from ectopic VSG117 or
endogenous VSG221 using qPCR in the
cells lines shown in Fig. 2A. Ectopic
VSG117 was expressed from
immediately behind the VSG221 ES
promoter, in the rDNA spacer, the tubulin
array or upstream of the procyclin loci.
VSG117 was flanked downstream by
either a VSG221 (VSG 30) or tubulin (Tub
30) UTR. The VSG221 or VSG117 single
expressers (SM221pur or SMD221/117
respectively) are shown as controls. VSG
transcript levels were normalised to actin.
There was significant downregulation of
endogenous VSG221 transcript in cells
expressing high levels of VSG117 from
either the VSG221 ES or the rDNA
spacer (* P< 0.05). The results are from
three biological replicates with the
standard deviation indicated with error
bars.
B. Western blot analysis of VSG117
expressed ectopically from the VSG221
ES, the rDNA locus, tubulin locus (tub) or
upstream of the procyclin loci (Pro).
VSG117 was flanked downstream with a
VSG221 or a tubulin 30UTR. The
VSG221 or VSG117 single expressers
(SM221 or SMD221/117 respectively) are
included for comparison. The blot was
probed for VSG117 or VSG221 with BiP
used as a loading control.
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effect on the VSG mRNA transcript was due to the VSG
30UTR rather than the adjacent 30 flanking regions. We
analysed trypanosomes expressing ectopic VSG117
flanked with chimeric VSG and a-tubulin 30 downstream
sequences (Supporting Information Figs S3 and S4).
High levels of expression of ectopic VSG117 were only
obtained if VSG117 was flanked with a VSG 30UTR,
even if the regions downstream of the polyadenylation
site were switched for those downstream of an a-tubulin
polyadenylation site (Supporting Information Figs S3
and S4). T. brucei genes tend to show variability in the
polyadenylation sites used (Siegel et al., 2010). Using
Rapid Amplification of 30 Ends (30RACE) (Scotto-Lavino
et al., 2006) we found that the preferred VSG poly-
adenylation site did not change in these chimeric 30
sequences, although there was an increase in use of
alternative VSG polyadenylation sites (Supporting Infor-
mation Fig. S4 and Table S1). This demonstrates that
the VSG 30UTR was the main factor in facilitating high
levels of expression of ectopic VSG117, and that this
was a consequence of a transcript stabilising effect of
the VSG 30UTR (Berberof et al., 1995).
As shown earlier, expression of a higher level of an
ectopic VSG117 resulted in a compensatory decrease
in levels of expression of the endogenous VSG221,
which was seen at both the RNA and protein level
(Fig. 3) (Supporting Information Fig. S1). Decrease in
endogenous VSG221 transcript was significant and
highly repeatable (* P<0.05). It has been previously
documented that expression of an ectopic VSG from a
tetracycline inducible T7 promoter leads to transcrip-
tional attenuation of the active ES telomere (Batram
et al., 2014). However, this attenuation is unstable, and
disappears within days. We did not find evidence for sig-
nificant transcriptional attenuation of the VSG221 ES
telomere when an ectopic VSG117 was expressed from
a location either immediately proximal to the active
VSG221 ES promoter, or from the rDNA spacer.
The VSG221 ES telomere contains unique sequences
including a single copy VSG pseudogene (pseudo
1.10100, and the VSG221 co-transposed region (CTR)
(Fig. 4A) (Davies et al., 1997). Unstable transcripts are
generated from these sequences. We saw a significant
reduction in VSG221 transcript when ectopic VSG117
Fig. 4. Expression of ectopic VSG117 leads to significant reduction in levels of VSG221 mRNA but no significant attenuation of transcription
at the active VSG221 telomere.
A. Schematic of the VSG221 ES telomere indicating the relative positions of a single copy VSG pseudogene (w), 70 bp repeats, the VSG221
co-transposed region (CTR) and VSG221. The ES promoter is indicated with a flag and telomere repeats with horizontal arrows. The
schematic is not to scale.
B. Quantification of RNA transcript levels corresponding to the VSG pseudogene, CTR or VSG221 in cells where ectopic VSG117 with a
VSG221 30UTR was inserted into the active VSG221 ES or an rDNA spacer using qPCR. Transcript levels were normalised against actin, and
data are presented as arbitrary units (2–DCt). The ‘single-expresser’ SM221pur (2211) and SMD221/117 (1171) cell lines, as well as the
HNI(VO2) cell line (V021) with an active VSGV02 ES are included as controls. As expected, there was significant reduction in levels of
VSG221 transcript on expression of ectopic VSG117 (* P< 0.05, one way ANOVA and Tukey post hoc). However, there was no significant
reduction in the level of other precursor RNAs derived from the VSG221 ES telomere. Results were derived from three biological replicate
experiments with standard deviation indicated with error bars.
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was expressed from either the ES or the rDNA spacer
(Fig. 4B) (P< 0.05). Quantification of the low abundance
transcripts from the VSG pseudogene or the CTR gave
a higher degree of variability than quantification of
VSG221 mRNA. However, we did not find evidence for
a statistically significant reduction in their abundance
in the presence of expression of ectopic VSG117
(Fig. 4B). This absence of significant transcriptional
attenuation argues that the inverse correlation in the
amounts of VSG117 and VSG221 that we observe (Sup-
porting Information Fig. S1) is operating at the level of
mRNA stability, and could be the consequence of a limit-
ing, and transcript stabilising VSG 30UTR binding protein.
A highly conserved 16-mer in the VSG 30 UTR is
essential for mRNA stability
Alignment of the VSG 30 UTR in 31 VSG cDNA sequen-
ces identified highly conserved 9-mer and 16-mer
sequences (Fig. 5A, Supporting Information Fig. S5)
(Borst and Cross, 1982; Berberof et al., 1995; Hutchin-
son et al., 2007). We determined the predicted second-
ary structure of these VSG 30UTRs using RNAfold
(ViennaRNA Package 2.0) (Gruber et al., 2008), and
found that most VSG 30 UTR sequences form a hairpin
with the 9-mer located in the loop (Fig. 5B). We, there-
fore, used mutational analysis to test the functional role
of these different VSG 30UTR sequences and hypotheti-
cal RNA folding structures. We expressed ectopic
VSG117 flanked downstream with a VSG117 30UTR
with scrambled 9-mer and/or 16-mer sequences
(Fig. 5C). In addition, we created mutations where we
abolished the predicted stem-loop structure or recreated
it using different sequences. Last, we mutated con-
served sequences at the 30 end of the VSG open read-
ing frame (Fig. 5C) (Supporting Information Table S2).
Constructs containing an ectopic VSG117 flanked
downstream with these mutant 30UTR sequences were
integrated within an active VSG221 ES in T. brucei
221VB1.1 (Sheader et al., 2005) (Fig. 6A). Endogenous
VSG221 was subsequently knocked down using tetracy-
cline inducible RNAi to assess the functionality of the
ectopic copies of VSG117. In most of the cell lines gen-
erated, relatively equal amounts of VSG117 and VSG221
transcript were expressed. However, VSG 30UTR muta-
tions 2 and 3 significantly affected levels of expression of
ectopic VSG117 (**P< 0.01), and mRNA levels were
reduced to 14–16% or 18–20% of wild type respectively
(Fig. 6B). The levels of VSG117 protein were also
reduced in a comparable fashion (Fig. 6C). These levels
of VSG117 expression were not high enough for func-
tional complementation, and cells arrested when endoge-
nous VSG221 transcript was knocked down with RNAi
(Fig. 6D). In some cases, trypanosomes eventually
escaped the VSG RNAi induced cell cycle arrest (Fig. 6D
mut 2), as has been observed previously (Aitcheson
et al., 2005; Sheader et al., 2005). This appears to be a
consequence of a negative selection pressure selecting
for cells which have escaped the VSG221 RNAi, either
through switching away from VSG221 or through muta-
tion of a component of the tetracycline inducible RNAi
machinery. In contrast, no growth reduction was seen in
T. brucei expressing VSG117 flanked by either a wild
type VSG 30UTR (navy dotted lines) or other mutant
VSG 30UTRs (Supporting Information Fig. S6). Thus, the
conserved 16-mer sequence which was shared between
VSG 30UTR mutations 2 and 3, is essential for functional
levels of VSG expression.
We next determined if the conserved 16-mer in the
VSG 30UTR plays a role in transcript stability. This was
indeed the case, and scrambling the 16-mer resulted in a
striking reduction in VSG117 transcript half-life from
113.96 6.0 min to 20.36 10.8 min (Fig. 7). In contrast,
the half-life of VSG221 transcript expressed from the
endogenous VSG221 gene was 40–60 min. This value for
the VSG221 mRNA half-life was significantly lower than
the 85–99 min observed earlier, which also corresponds
with previously published data (Supporting Information
Fig. S2) (Hoek et al., 2002). This apparent decrease in
VSG221 mRNA half-life is presumably due to the pres-
ence of a VSG221 RNAi construct in these cells, which is
absent in the cells used for the data presented in Sup-
porting Information Fig. S1. Even in the absence of tetra-
cycline, leaky VSG221 RNAi presumably degrades
VSG221 mRNA transcript enough to result in an apparent
decrease of the VSG221 half-life. In support of this expla-
nation, the measured half-life of VSG117 mRNA (which
would not be affected by VSG221 RNAi) does not differ
drastically between these two different types of cell lines.
Alterations in the polyadenylation site used would
affect the length of the 30UTR, which could potentially
impact on mRNA stability (Elkon et al., 2013). However,
using 30RACE we did not find a change in the preferred
polyadenylation site used for the mRNA of ectopic
VSG117 (Supporting Information Table S3). It is, there-
fore, possible that an RNA binding protein targeting the
conserved 16-mer in the VSG 30UTR stabilises the VSG
transcript, although it cannot be excluded that RNA
binding proteins binding elsewhere in the transcript are
also involved (Clayton, 2014).
Expression of ectopic VSG117 from the rDNA locus is
heterogeneous and does not provide functional levels of
expression
Analysis of T. brucei expressing ectopic VSG117 from the
active VSG221 ES showed that both VSG117 as well as
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VSG221 (encoded by the endogenous VSG221 gene) were
present at the cell surface, and similar homogeneous levels
were observed on individual cells (Fig. 8). However, in con-
trast when VSG117 was expressed from the rDNA spacer,
very heterogeneous levels of VSG117 expression were
observed in the population. This variability is presumably a
consequence of stochastic changes in the activation state of
the rDNA transcription unit.
We, therefore, compared the relative levels of
VSG117 expressed from either the Pol I- transcribed ES
Fig. 5. Mutational analysis of highly conserved features of the VSG 30 UTR.
A. Schematic of the VSG117 gene with untranslated regions (UTR) and open reading frame (ORF) indicated. Sequence of the VSG117 30
UTR is shown with relevant sequences indicated with boxes including the GPI anchor addition sequence (GPI add.), the stop codon, and
sequences that are highly conserved in functional VSG transcripts: the 9-mer and the 16-mer. In addition, a highly conserved sequence at the
30 end of the VSG ORF is shown which encodes a Leu-Leu dipeptide which is part of the GPI anchor addition signal.
B. Predicted RNA secondary structure of the VSG117 or VSG221 30 UTR as determined using RNAfold (ViennaRNA Package 2.0). The
positions of relevant features in the predicted RNA structures are highlighted with black lines. The colours of the dots indicate the probability
of RNA nucleotides being unpaired from unlikely (blue5 0) to highly likely (red5 1).
C. Overview of six VSG117 30 UTR mutations generated to probe the essentiality of specific highly conserved sequences, as well as predicted
VSG UTR secondary structure. Mutations 1–3 scrambled the sequences of the conserved 9-mer and/or 16-mer. Mutations 4 and 5 either
abolished the stem-loop structure, or maintained its structure but changed its sequence. Mutation 6 mutated a conserved sequence within the
VSG117 ORF without disrupting the GPI anchor addition sequence. The sequences of the VSG 30 UTR mutations analysed are in the
Supporting Information.
Genomic features facilitating high VSG expression 621
VC 2017 The Authors. Molecular Microbiology Published by John Wiley & Sons Ltd., Molecular Microbiology, 106, 614–634
or the rDNA. If VSG117 was expressed from the
active VSG221 ES in ‘double-expresser’ T. brucei,
VSG117 transcript levels were approximately 40.46 9.1%
those of a ‘single-expresser’ (Supporting Information
Fig. S7A). Similarly, at the population level transcript lev-
els from a gene inserted in the rDNA spacer were approx-
imately 31.465.6% of a ‘single-expresser’. Similarly at
the protein level, VSG117 expressed from the active ES
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was 54.16 6.1% ‘single-expresser’ levels, while there
was marginally reduced expression from the rDNA
spacer (41.9617.3% levels of a VSG117 ‘single-
expresser’) (Supporting Information Figs S6B and
S6C). Both the SM221/117 and 221rD117 cell lines
include VSG221 RNAi constructs. However, in the
absence of tetracycline, we do not think that leaky
expression from these constructs significantly impacts
on our measurements. The expression of ectopic
VSG117 appears to increase after knock-down of
VSG221 in the SM221/117 cells, but not in the
221rD117 cell-line. However, this is presumably a con-
sequence of the SM221/117 (but not 221rD117) cells
continuing to proliferate, and thereby skewing the popu-
lation towards VSG117 expressers.
A precise cell cycle arrest is not triggered in cells stalled
by the expression of ectopic VSG from the rDNA spacer
We next asked if VSG117 expressed from the rDNA
spacer could functionally complement the cell if VSG221
synthesis was knocked down using RNAi (Fig. 9A). In
the presence of VSG221 RNAi all T. brucei clones
investigated stalled abruptly, indicating that expression
of ectopic VSG117 from the rDNA spacer was not
adequate for survival (Fig. 9B). We next performed cell
cycle analysis on cells that had stalled after VSG221
synthesis was blocked in the presence of expression of
ectopic VSG117 from the rDNA (Fig. 9C). Cells in G1
have one kinetoplast (K) and one nucleus (N). As they
enter S phase, first the kinetoplast divides (2K1N), and
then mitosis occurs generating (2K2N) cells. In the
parental T. brucei SM221 221RNAi cell line, there was
an expected accumulation of 2K2N cells after the induc-
tion of VSG221 RNAi from 7.36 2.1% to 57.762.6%
(Sheader et al., 2005). If VSG221 RNAi was induced in
the presence of ectopic VSG117 expressed from the
rDNA spacer, an increase in 2K2N cells was also
observed (9.96 2.3% to 34.767.3%). However, strik-
ingly, there was also an increase in multi-nucleated cells
(‘others’) (0.36 0.6% to 29.26 3.4%) (*P< 0.05)
(Fig. 9D). Most of these multi-nucleated cells had four
nuclei (66.96 6.1%) (*P< 0.05) indicating that they had
stalled prior to cytokinesis, but had re-entered S-phase.
Therefore, although VSG expression levels from the
rDNA were not consistently at high enough levels to
allow cytokinesis, they were also not consistently low
enough to trigger the precise ‘VSG synthesis block’ cell-
cycle checkpoint. There were relatively few cells with
more than four nuclei. Possibly the concurrent (and pre-
viously documented) global translation arrest prevented
cells from reinitiating S phase more than once (Smith
et al., 2009).
Discussion
Extraordinarily high levels of VSG are expressed from a
single active VSG gene in bloodstream form T. brucei.
Here we investigate the role of different genomic fea-
tures facilitating this. We show that functional levels of
VSG could be expressed from an ectopic VSG gene
located more than 60 kb upstream of its normal telo-
meric location within the active ES. A VSG 30UTR was
key for high VSG expression levels, and a conserved
16-mer sequence was essential for stabilising the VSG
transcript. High levels of VSG expression were only
obtained from Pol I-transcribed loci including the ES and
the rDNA. However, these two different Pol I transcrip-
tion units were not comparable. Expression of ectopic
VSG from the rDNA spacer was highly heterogeneous
at the population level, presumably as a consequence of
variability in the activation state of the ectopic rDNA pro-
moter and surrounding rDNA transcription units. VSG
expressed from the rDNA spacer did not functionally
Fig. 6. The conserved 16-mer sequence within the VSG 30UTR is essential for high levels of VSG expression.
A. Schematic of the cell line used for the VSG 30UTR studies. Constructs containing VSG117 flanked downstream by either wild type (WT) or
mutant VSG117 30 UTRs were inserted into the active VSG221 expression site (ES) of the bloodstream form T. brucei 221VB1.1 cell line. The
selectable marker was a puromycin (Pur) resistance gene. VSG221 RNAi can be induced in this cell line, which allows one to establish if
ectopic VSG117 can compensate for lack of VSG221 transcript. Promoters are indicated with flags and transcription with arrows.
B. Levels of VSG117 and VSG221 transcript as determined using qPCR. RNA was isolated from cell lines expressing ectopic VSG117 flanked
downstream by either a wild type VSG117 UTR, or a VSG117 UTR with mutations in conserved features. The VSG 30UTR mutant numbers
(1–6) are described in Fig. 5C. RNA from the SM221pur (2211) or SMD221/117 (1171) ‘single-expresser’ strains is analysed as a control.
Values normalised against actin are shown in arbitrary units (2-DCt), with the amount of VSG221 (red bars) or VSG117 (green bars) transcript
shown as the mean of three independent experiments with the standard deviation indicated with error bars. The only significant reduction in
VSG117 transcript compared with wild type (WT) was in mutants m2 and m3 containing scrambled 16-mer sequences (** P< 0.01).
C. Western blot analysis of VSG levels in T. brucei expressing ectopic VSG117 with either a wild type (WT) or mutant VSG117 30 UTRs (m1–
m6). Protein lysates were isolated from the cell lines analysed in panel B. Protein from two clones of each mutant are shown in comparison
with ‘single-expresser’ cell lines SM221pur (VSG2211) or SMD221/117 (VSG1171). VSG117 or VSG221 were probed for, with BiP serving
as a loading control.
D. The conserved 16-mer present in the VSG 30UTR is required for functional levels of VSG expression. Growth curves were performed in
VSG221 expressing T. brucei cell lines expressing ectopic VSG117 with either a wild type (WT) or a mutated VSG 30UTR (Mutant 2 or Mutant
3). VSG221 RNAi was induced in the presence (1) or absence (-) of tetracycline. Two clones are shown for each mutant (c1 and c2). Results
are the mean of three independent experiments with standard deviation indicated with error bars.
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Fig. 7. Mutation of a conserved 16-mer sequence within the VSG 30 UTR results in a drastic reduction in VSG transcript half-life.
A. Sequence of a relevant segment of the VSG117 30 UTR with the conserved 9-mer and 16-mer sequences highlighted with boxes. The wild
type (WT) 16-mer sequence is shown, as well as the scrambled version present in Mutant 2 (mut 2). Relevant nucleotide numbers are shown
in relation to the start of the 30 UTR.
B. Decrease in VSG RNA half-life when the conserved 16-mer in the VSG117 30UTR is scrambled. RNA was isolated from cell lines
expressing VSG117 with a wild type (WT) VSG 30UTR (T. brucei SM221/1171WT 30UTR) or a VSG 30 UTR with a scrambled 16-mer (T.
brucei SM221/1171mut2 30UTR). Cells were incubated with sinefungin to block trans-splicing and actinomycin D to inhibit transcription, and
total RNA was harvested at different time points. Transcript levels were determined by qPCR. Results are presented as a ratio of transcript
levels obtained from single-expresser cell lines expressing either only VSG117 or VSG221. The mean of three independent experiments is
shown with the standard deviation indicated with error bars.
C. The half-life in minutes (min) of VSG117 (red bars) or VSG221 (green bars) transcript in cell lines where ectopic VSG117 has either a wild
type (WT) or mutant 2 (mut2) 30UTR. Results are the mean of three independent experiments with the standard deviation indicated with error
bars.
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Fig. 8. Heterogeneous levels of expression of ectopic VSG117 expressed from an rDNA spacer compared with an ES.
Immunofluorescence analysis was performed on T. brucei expressing an ectopic copy of VSG117 from within the active VSG221 ES, the
rDNA spacer, the tubulin array or upstream of a procyclin locus. The flanking 30UTR was from VSG221 or tubulin. Panels show T. brucei
visualised with differential interference contrast (DIC), or reacted with a rabbit polyclonal antibody specific for VSG221 or a mouse monoclonal
against VSG117. The scale bar indicates 10 mM.
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complement the cell. The cells arrested prior to cytoki-
nesis, as was also observed after blocking VSG synthe-
sis. However, many cells re-entered S-phase, indicating
that VSG levels were not consistently low enough to
trigger the precise ‘VSG synthesis block’ cell cycle
checkpoint in all cells.
There is approximately 700-fold more VSG mRNA
than ESAG1 mRNA generated in bloodstream form T.
brucei, even though these two different genes are tran-
scribed from the same polycistronic ES transcription unit
(Cully et al., 1985). The VSG 30UTR has previously
been shown to play a role in stabilising transcript from a
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CAT reporter gene three-fold compared to CAT without a
flanking 30UTR in bloodstream form T. brucei (Berberof
et al., 1995). These experiments also showed that intro-
ducing a VSG 30UTR downstream of the CAT reporter
gene resulted in its developmental regulation. Here, we
also show that the VSG 30UTR is essential for the pro-
duction of functional levels of VSG transcript, and show
essentiality of the conserved VSG 30UTR 16-mer
sequence, which when scrambled resulted in a dramatic
reduction in VSG transcript half-life from 113.966.0 to
20.36 10.8 min.
Transcriptomic analyses comparing mRNA stability at
a whole genome level have shown that the median half-
life of mRNA transcripts in bloodstream T. brucei is 13
min (Manful et al., 2011; Clayton, 2014; Fadda et al.,
2014). The VSG transcript has an unusually long half-
life. It is possible that this is due to a protein binding the
conserved 16-mer in the VSG 30UTR. On disruption of
this putative interaction, VSG transcript stability was
reduced down to a level which is average for mRNA in
bloodstream form T. brucei. This hypothetical 16-mer
binding factor could act directly to protect the mRNA
transcript from degradation by physically blocking asso-
ciation with a nuclease. Alternatively these 16-mer
sequences, or a protein binding them could promote
translation. There is evidence that translation is a major
factor in preventing mRNA decay in T. brucei, and inhibi-
tion of translation with different inhibitors including cyclo-
heximide and puromycin significantly reduces the half-
life of VSG mRNA (Ehlers et al., 1987; Delhi et al.,
2011). Using in vitro methods, we have not yet been
successful in identifying a hypothetical RNA binding
protein.
Mutation of the conserved 9-mer sequence did not
have an observable effect on transcript functionality.
However, the VSG 30UTR is not only important for tran-
script stability, but also plays a role in DNA recombina-
tion. During a chronic infection, new VSG variants are
frequently copied into the active ES via gene conversion
(Vink et al., 2012; McCulloch et al., 2015). Upstream
homology is provided by characteristic 70 bp repeats,
and downstream homology by conserved regions in the
VSG 30UTR (Hovel-Miner et al., 2016). In addition to
affecting transcript stability, these 30UTR sequences
including the conserved 9-mer could, therefore, play an
additional role in facilitating gene conversions.
We show that functional VSG levels could be obtained
from an ES promoter proximal VSG gene located 60 kb
upstream of its normal location at the chromosome end.
However, in wild-type T. brucei the active VSG is invaria-
bly the last gene within the ES, and adjacent to the telo-
mere repeats. One explanation for this highly conserved
genomic architecture of the ES, is that the telomere
proximal location of VSG could facilitate VSG silencing
in inactive ESs. There is a low level of leaky transcrip-
tion from ‘inactive’ ES promoters, which attenuates
within the ES (Vanhamme et al., 2000; Kassem et al.,
2014). The chromatin protein TbRAP1 mediates a
repressive silencing gradient operating on inactive ESs,
which is stronger immediately near the telomere end,
compared with 60 kb upstream (Yang et al., 2009;
Nanavaty et al., 2017). Efficient suppression of tran-
scription of VSGs located in silent ESs is essential for
the mono-allelic expression of the active VSG (Durai-
singh and Horn, 2016). The region immediately proximal
to the telomere repeats within the inactive ES could,
therefore, be the most transcriptionally silent location
within the ES to locate VSG.
In addition, the invariably telomeric location of the
active VSG would facilitate the DNA rearrangements
mediating VSG switching. DNA recombination reactions
at telomeres mediate the generation of sequence diver-
sity within polymorphic gene families involved in pheno-
typic or antigenic variation which are frequently
telomeric (Keely et al., 2005; Scherf et al., 2008; de Las
Penas et al., 2015; Lue and Yu, 2017). In T. brucei this
is also the case, and the telomeric VSG can be
switched either through telomere exchange or through
Fig. 9. VSG expressed from the rDNA spacer does not functionally complement the cell and results in cells arresting precytokinesis without
triggering a characteristic ‘VSG synthesis block’ cell-cycle checkpoint.
A. Schematic of the T. brucei 221rD117 221RNAi cell line. Transcription of the active VSG221 ES is selected for using a puromycin resistance
gene (purple box). A construct containing VSG117 (red box) and a hygromycin resistance gene (blue box) is integrated in a tagged rDNA
spacer. VSG221 RNAi was induced using a tetracycline inducible RNAi stem-loop construct inserted in the rDNA (indicated with black boxes).
The ES promoter is indicated with a white flag, the rDNA promoter with black flags, the tetracycline inducible promoter with an arrow, and the
tetracycline inducible rDNA promoter indicated with an asterisk.
B. Growth curves in the presence (1) or absence (-) of tetracycline induced VSG221 RNAi. The SL221 cell line that does not contain ectopic
VSG117. Four T. brucei 221 rD117 221 RNAi clones expressing ectopic VSG117 from the rDNA are compared (rD c1-c4). The cell density
over time was monitored. Results are from three biological replicates with the standard deviation indicated with error bars.
C. Cell karyotype was determined using microscopy with cells where the DNA was stained with DAPI. The numbers of kinetoplasts (K) or
nuclei (N) were determined with the expanded section detailing the karyotype of cells described as ‘others’. The number of cells described as
‘others’ was significantly increased (*P< 0.05, unpaired t test) when VSG221 RNAi was induced in cells where ectopic VSG117 was
expressed from the rDNA spacer (221rD117 221RNAi) compared to when there is no ectopic VSG expressed. Standard deviation from three
biological replicates is indicated with error bars (n  200 was counted for each time point in all biological replicates).
D. Within the karyotype category of ‘others’, there was a significant predominance of cells with 4 nuclei, indicating that they had undergone an
additional round of re-initiation of S phase (*P< 0.05, ANOVA followed by Tukey post hoc).
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gene conversions (Li, 2015; McCulloch et al., 2015).
Subtelomeres in T. brucei are particularly fragile regions
of the genome, and are susceptible to DNA strand
breaks facilitating VSG switching (Glover et al., 2013a;
Nanavaty et al., 2017). An important reason that VSGs
are invariably located at the ends of the ES transcription
units, is presumably because this is the most recombi-
nogenic place for them to be (Hovel-Miner et al., 2012).
High levels of ectopic VSG could only be expressed
from Pol I transcription units including the ES and the
rDNA, compared with the low levels obtained from the
Pol II- transcribed ab-tubulin transcription unit. Pol I
transcription units are unique in being transcribed at an
extremely high rate, facilitated by both high rates of
RNA polymerase initiation, and density of polymerase
loading on the DNA template (French et al., 2003; Vik-
torovskaya and Schneider, 2015). In T. brucei this is
also the case, and it has been estimated that a marker
inserted in a Pol I transcription unit is transcribed at a
10-fold higher rate than one inserted in a Pol II tran-
scription unit (Biebinger et al., 1996). Pol I-derived tran-
scripts are uncapped, and, therefore, untranslateable
(Grummt and Skinner, 1985). However, as T. brucei
adds a capped Pol II-derived spliced leader RNA to the
50 ends of its mRNAs through trans-splicing, it can use
Pol I to direct expression of protein coding genes
(Gunzl, 2010). T. brucei, therefore, appears to have
recruited its strongest (Pol I) promoter to direct tran-
scription of VSG.
In our experiments, expression of ectopic VSG117
from a variety of genomic locations appeared to lead to
a decrease in levels of the endogenous VSG221 tran-
script, with the relative levels of the two VSGs approxi-
mately inversely correlated with each other. In previous
experiments by Batram et al, expression of a second
ectopic VSG from a tetracycline inducible T7 promoter
resulted in down-regulation of the endogenous telomeric
VSG through chromatin mediated silencing of the active
ES telomere (Batram et al., 2014). In contrast, we did
not see a statistically significant decrease in transcrip-
tion of the active VSG221 ES telomere after expression
of ectopic VSG117 from either the ES or the rDNA
spacer.
The discrepancy of our results with those of Batram
et al is presumably a consequence of exactly how the
ectopic VSG is expressed. Batram et al. investigate a
transient phenomenon which occurs within an 8 h
period, as the induction of the T7 promoter rapidly
directs large amounts of transcription of the ectopic
VSG. This resulted in the generation of stumpy forms,
possibly as a consequence of a stress response
(Batram et al., 2014; Zimmermann et al., 2017). It has
been shown that as T. brucei differentiates to the
stumpy form, transcription of the active VSG is silenced
through transcription attenuation progressing upwards
along the ES from the chromosome end (Amiguet-
Vercher et al., 2004). It is, therefore, possible that the
transcriptional attenuation of the active ES observed by
Batram et al. is a result of the cell becoming ‘stumpy-
like’, rather than a direct consequence of expression of
the ectopic VSG as such. In this inducible system,
expression of the ectopic VSG is silenced within a num-
ber of days through an unknown mechanism, and
expression of the endogenous VSG returns to normal.
In contrast in our experiments, we investigated stable
transformants which have adjusted to the expression of
a second ectopic VSG. As the amount of endogenous
VSG221 transcript was consistently in approximately
inverse proportion to the amount of ectopic VSG
expressed, our results are best explained by the pres-
ence of a factor binding the VSG 30UTR. If this protein
is not in excess, it would restrict the total amount of
VSG transcript which can be stably expressed in
the cell.
Although VSG ESs and rDNA transcription units are
both transcribed by Pol I, they show very different prop-
erties. Expression of ectopic VSG117 located within the
active ES resulted in homogeneous expression of
VSG117. In contrast, expression of ectopic VSG117
from a specific tagged rDNA promoter within the Pol
I-transcribed rDNA spacer resulted in highly heterogene-
ous VSG117 expression at the population level. It has
been shown earlier that not all rDNA loci in T. brucei are
equivalent, and that varying levels of expression can be
generated from constructs integrated into different rDNA
spacers (Alsford et al., 2005). To eliminate complications
due to this putative position effect, we have performed
all of our analyses using a single tagged rDNA locus. In
addition to possible position effects, it has earlier been
shown that ectopic expression of proteins from an rDNA
promoter was reduced at high cell culture densities in
bloodstream form T. brucei (Ali and Field, 2013). To
eliminate this complication, we have performed all of our
experiments using mid-logarithmic stage parasites at
approximately equivalent cell densities.
Our data showing heterogeneous levels of expression
from a single tagged rDNA locus is, therefore, presum-
ably due to alternating activation states of the T. brucei
rDNA promoter. It has been shown that rDNA transcrip-
tion units in Saccharomyces cerevisiae and mammalian
cells exist in different fluctuating activation states. Within
an individual cell, typically about half of the rDNA tran-
scription units are transcriptionally active, while the other
half are silenced at the level of chromatin (McStay and
Grummt, 2008; Grummt and Langst, 2013; Hamperl
et al., 2013). This is presumably also the case in T. bru-
cei. This very different transcriptional behaviour between
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the ES and rDNA highlights key differences in these Pol
I transcription units.
The inability of VSG expressed from an rDNA pro-
moter to functionally complement the cell is presumably
due to fluctuating levels of activity of the rDNA promoter.
However, these stalled cells did not universally trigger a
‘VSG synthesis block’ cell cycle checkpoint (Sheader
et al., 2005). Although there was a large accumulation
of post-mitotic 2K2N cells there was also a significant
increase in multi-nucleated cells, indicating that they had
reinitiated S-phase. This argues that the ‘VSG synthesis
block’ checkpoint is a stress response, which is the con-
sequence of consistent depletion of VSG in all cells.
The pulsating levels of VSG expressed from the rDNA
promoter possibly allowed more cells to proceed through
G1 (1K1N) to a precytokinesis stage (2K2N), after which
some cells then reinitiate S-phase. It will be interesting
to determine exactly how much continuous depletion of
VSG is required to trigger this unique cell-cycle check-
point, and how VSG levels are likely being sensed.
In summary, we identify key features required for the
expression of functional levels of VSG in bloodstream
form T. brucei. Not only must the active VSG be located
within a Pol I-transcribed ES, but it needs to be flanked
by a VSG 30UTR with a conserved 16-mer sequence.
Our experiments also highlight critical differences
between the ES and rDNA Pol I transcription units.
Although very high levels of expression can be generated
from rDNA promoters, these levels fluctuate, and are not
sufficient to generate functional levels of VSG expression.
These results highlight the molecular adaptations that the
bloodstream form trypanosome has adopted to ensure
that 10% of its protein can be produced from a single Pol
I-transcribed VSG gene. They also highlight the essential-
ity of close to normal levels of VSG expression for the
viability of bloodstream form T. brucei, allowing it to be
an effective pathogen of the mammalian bloodstream.
Experimental procedures
Trypanosome strains and culturing
Bloodstream form Trypanosoma brucei brucei 427 was used
for all experiments and was cultured in HMI-9 medium with
15% foetal calf serum. All cell lines used in this study are
detailed in Supporting Information Table S4. Many are based
on the T. brucei ‘single marker’ SM cell line (Wirtz et al.,
1999) or a derivative with a puromycin resistance gene (pur)
incorporated immediately behind the promoter of the active
VSG221 ES (SM221) (Narayanan et al., 2011; Stanne et al.,
2011) where it is called S16.221. The presence of a select-
able marker in the active VSG ES prevents switching to
another VSG ES. The T. brucei cell line expressing both
VSG117 and VSG221 has an ectopic copy of VSG117
inserted immediately behind the promoter of the active
VSG221 ES. Here VSG117 has an a-tubulin splice site and
a VSG221 downstream region containing the VSG221
30UTR and polyadenylation signal (Smith et al., 2009). To
generate a cell line dependent on VSG117 expressed from
the VSG221 ES, the subtelomeric VSG221 gene in T. brucei
SM221/117 was exchanged with a blasticidin resistance
gene using the pBSVSG221KOblast construct to generate T.
brucei SMD221/117. Otherwise, all other constructs inte-
grated in the VSG221 ES in this study were targeted 216 bp
downstream of the transcription start site.
To study the effect of VSG117 expression from different
T. brucei genomic loci, constructs containing a hygromycin
resistance gene and VSG117 were integrated into different
genomic regions in the T. brucei SM221pur cell line. In
these constructs, VSG117 was flanked upstream by aldol-
ase RNA processing sequences, and downstream by either
the VSG221 downstream region (containing the 30UTR and
polyadenylation signal) or the intergenic region downstream
of an a-tubulin gene. These ectopic copies of VSG117
were targeted to the active VSG221 ES (T. brucei SM221/
117VSG30UTR and SM221/117Tub30UTR), the a-b tubulin
array (SM221/tub117VSG30UTR and SM221/tub117-
Tub30UTR), and upstream of the PARP B1 procyclin locus
(SM221/pro117VSG30UTR and SM221/pro117Tub30UTR)
(Rudenko et al., 1990). To integrate VSG117 into a specific
rDNA spacer, a ‘landing-pad’ construct (prDNATargr-
ProeGFPBSD) containing eGFP and a blasticidin resistance
gene was first used to create the T. brucei SM221/
rDNAeGFP cell line. Subsequently, this cell line was used
to integrate VSG117 into this marked rDNA spacer using
the same rDNA targeting sequence and part of the blastici-
din gene for homology (SM221/rDNA117VSG30UTR and
SM221/rDNA117Tub30UTR). In constructs used to integrate
VSG117 into either the procyclin locus or the rDNA spacer,
an rDNA promoter in the construct directed transcription of
the drug resistance gene and VSG117.
A construct containing VSG117 with downstream chi-
meric 30 sequences was integrated into the active VSG221
ES of the T. brucei SM221pur cell line (SM221/117 VSG-
Tub30and SM221/117 Tub-VSG30). In VSG-Tub, the chi-
meric 30 sequences are composed of the VSG221 30UTR
(76 bp) flanked by sequences immediately downstream of
the a-tubulin 30UTR (187 bp). In Tub-VSG the a-tubulin
30UTR (92 bp) is flanked by VSG221 sequences immedi-
ately downstream of the VSG221 30UTR (538 bp).
Six VSG117 30UTR mutants were generated to analyse
the VSG 30UTR in more detail. Details of the mutations are
in shown in Fig. 5 and Supporting Information Table S2.
Constructs contained a puromycin resistance gene and a
VSG117 gene preceded by an a-b tubulin intergenic region
and flanked downstream by a VSG117 30UTR which was
either wild type or mutant. These were integrated into T.
brucei 221VB1.1 (Sheader et al., 2005), thereby replacing
the blasticidin resistance cassette present in the VSG221
ES. This cell line contains a VSG221 RNAi construct with
opposing tetracycline inducible T7 promoters. The T. brucei
SM221/117 221RNAi cell line is referred to as T. brucei
221VP117 in (Smith et al., 2009). T. brucei 221rD117
221RNAi is T. brucei SM221/rDNA117VSG30UTR with a
stem-loop VSG221 RNAi construct generated from
pLEW100v5xPEX11 (Silverman et al., 2011). The T. brucei
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SL221 cell line is T. brucei SM221pur transfected with this
stem-loop VSG221 RNAi construct. The VSGV02 express-
ing cell line T. brucei HNI(V02)(Rudenko et al., 1998) was
also used in Western blot and qPCR analyses.
DNA constructs
The DNA constructs used in this study are detailed in Sup-
porting Information Table S4. Primers used for cloning are
shown in Supporting Information Table S5. Additional
sequences and cloning details are available on request.
The construct pBSVSG221KOblast contains a blasticidin
resistance gene between VSG221 upstream (706 bp) and
downstream (602 bp) sequences which provided RNA proc-
essing signals and served as targeting fragments. Sequen-
ces which were used to target constructs immediately
downstream of the VSG221 ES promoter can be found in
(Sheader et al., 2004). In constructs where ectopic
VSG117 was integrated into different genomic locations,
the hygromycin gene is flanked upstream by a tubulin splice
acceptor sequence and downstream by an aldolase inter-
genic region containing polyadenylation sequences and a 50
splice acceptor site. The VSG117 gene was flanked down-
stream by VSG221 30 sequences including a 30UTR and
polyadenylation sequences. In addition, analogous con-
structs had VSG117 flanked with the 30 downstream region
from a-tubulin. These ectopic copies of VSG117 were
inserted into various genomic loci. These include immedi-
ately downstream of the VSG221 ES promoter, within a
specific rDNA spacer, within the constitutively transcribed
tubulin array (a and b tubulin genes indicated with grey
boxes) or upstream of the silent procyclin transcription
units. To integrate VSG117 into a tagged rDNA spacer
selected for high expression, the same rDNA upstream tar-
geting was used as in prDNA Targ rPro eGFP BSD.
To generate the VSG-Tub chimeric 30 sequences, the
VSG221 30UTR and a-tubulin downstream sequences
were amplified from the p221_1171VSG30UTR and
p221_1171Tub30UTR constructs respectively using a long
primer which covers the join between the 30UTR and the
downstream sequences. Subsequently these PCR products
were used as the template in a third PCR reaction with a
primer annealing to the start of the VSG 30UTR and a
primer annealing to the end of the a-tubulin downstream
sequence. A similar process was followed to produce the
Tub-VSG chimeric 30sequences. To generate the VSG
30UTR mutant constructs, a plasmid containing VSG117
flanked downstream by the VSG221 30UTR and down-
stream sequences was digested with PstI and XbaI to
exchange part of the VSG117 ORF and the VSG221
30UTR with 277 bp of synthesised DNA (either wild type or
mutant)(GenScript). The VSG117 UTR was flanked down-
stream with VSG221 polyadenylation sequences, as
VSG117 polyadenylation sequences are not available in our
T. brucei cell line. The entire VSG117 ORF with VSG117
30UTR and VSG221 downstream sequences was then
cloned into p221purVSG117UTR (Smith et al., 2009) to cre-
ate the 30UTR mutant series of constructs. The stem loop
RNAi construct targeting VSG221 was generated from
pLEWv5xPEX11 (Silverman et al., 2011).
Western blot analysis
For chemiluminescent experiments, cells were washed
once at 48C, and lysed in protein lysis buffer (50 mM Hepes
pH 7.5, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl2,
1 mM EGTA, a protease inhibitor tablet (Roche), and incu-
bated at 48C for 20 minutes on a rotating wheel. Prior to
SDS-PAGE, the protein lysates were combined with 4x pro-
tein loading buffer and boiled for 5–10 minutes. Protein
lysates were electrophoresed on a 10% resolving gel and
transferred onto a Hybond-P membrane (GE Healthcare).
The membrane was probed with rabbit polyclonal antibod-
ies against VSG221, VSG117 or BiP. Protein was visualised
using anti-rabbit ECL peroxidase (GE Healthcare) and
Super Signal West Pico chemiluminescent substrate
(Thermo Scientific).
In the Li-Cor Western blotting experiments cells were
lysed in 50 mM HEPES (pH 7.5); 1 mM EGTA; 1.5 mM
MgCl2; 10% (v/v) glycerol, 1% (v/v) Triton X-100 with a
cocktail of protease inhibitors (2 ug/ml of leupeptin, chy-
mostatin, pepstatin and antipain). Protein lysate was sus-
pended in loading buffer, and boiled at 1008C for 10 min
before loading. The equivalent of 2 3 104 cells per well
was electrophoresed and transferred onto Hybond-P mem-
brane. Blots were probed in Odyssey Blocking buffer (Li-
Cor) and washed with 0.1% PBS-Tween between probes.
Blots were probed with the rabbit primary antibodies (from
Jay Bangs): anti-VSG221, anti-VSG117 and anti-BiP and
the mouse KMX-1 antibody (from Keith Gull). Secondary
antibodies used were: IRDye 680LT anti-rabbit IgG (H1 L)
and IRDye 800CW anti-mouse IgG (H1 L) (both from
Li-Cor). Protein bands were visualised and quantified using
the OdysseyVR Infrared Imaging System.
Immunofluorescence microscopy
For immunofluorescence microscopy experiments, cells
were washed twice in cold PSG buffer and fixed with 2%
paraformaldehyde at room temperature for 15 min. Cells
were washed twice in PBS buffer and allowed to settle on
ColorFrost Plus microscopy slides (Shandon) for 30 min in
a humidity chamber. The slides were then washed with
PBS buffer and probed simultaneously with either rabbit
polyclonal anti-VSG221 or mouse monoclonal anti-VSG117
(both kind gifts from Jay Bangs) followed by AlexaFluor 488
conjugated goat anti-rabbit (Invitrogen) and Dylight 594
conjugated goat anti-mouse (Thermo). All probing steps
were carried out for 45 min in a humidity chamber and fol-
lowed by a wash with PBS buffer. The slides were subse-
quently mounted in Vectashield with DAPI (Vector
Laboratories). Cells were imaged with an M1 Imager fluo-
rescence microscope (Zeiss) using an AxioCam MRm cam-
era. Post-acquisition analyses were carried out with ImageJ
(National Institutes of Health, Bethesda, MD, USA).
RNA analysis
Total RNA was isolated using a Qiagen RNeasy Mini Kit
(Qiagen) and genomic DNA was removed using TurboD-
NAse (Ambion), and DNase removed using DNAse
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Inactivation Reagent (Ambion) according to the manufac-
turer’s instructions. Synthesis of cDNA was carried out with
100 ng RNA per sample using an Omniscript RT kit (Qia-
gen). qPCR reactions were performed using Brilliant II
SYBR low ROX master mix (Agilent) with relevant primers
(Supporting Information Table S6) using an Applied Biosys-
tems 7500 real time PCR machine. qPCR reactions were
performed with 1 ml cDNA diluted ten-fold with the excep-
tion of the mRNA decay assays where the cDNA was
diluted 100-fold. Relative quantification of mRNA was per-
formed with each sample normalised to levels of actin tran-
script. Unless stated otherwise, qPCR data are presented
as arbitrary units (2-DCt). Primers used for qPCR to detect
VSG221 transcript amplify a region of the VSG221 gene
located at 1058–1184 bp, and downstream of the region
used for VSG221 RNAi (106–910 bp). Predicted RNA sec-
ondary structure was determined using RNAfold (University
of Vienna) (ViennaRNA Package 2.0) (Gruber et al., 2008).
RNA stability and polyadenylation site analysis
For the mRNA stability assays, bloodstream form T. brucei
was grown to midlog phase (1 3 106 cells ml21). Cells
were incubated with Sinefungin (Millipore) at 5 mg ml21 for
5 min at 378C to inhibit trans-splicing and Actinomycin D
(10 mg ml21) was added to block transcription. Cells were
harvested at various time points, RNA was isolated and
cDNA generated and quantified as detailed above. For the
mRNA stability experiments, VSG mRNA was quantified in
comparison with 28Sb rRNA rather than actin. Mean values
were calculated with data from three independent experi-
ments. Primer sequences used for qPCR are shown in
Supporting Information Table S6.
Analysis of RNA polyadenylation sites was carried out
using 30 RACE (Rapid amplification of cDNA ends) based
on methods described in (Scotto-Lavino et al., 2006) with
minor variations. Briefly RNA (1 mg) was incubated at 808C
for 3 min, then placed on ice. cDNA was generated using
Omniscript (Qiagen) and the QT primer (50 ng) in a 20 ml
reaction mix. Samples were incubated for 5 min at room
temperature, 428C for 1 h, 508C for 10 min, then 708C for
15 min. At the end of the reaction 1 ml TE buffer was
added. PCR was performed as described in (Scotto-Lavino
et al., 2006) using the Q0 RACE primer and the VSG117
specific RACE primer for the first round and the Q1 RACE
primer paired with VSG117 primer 2 for the second. PCR
products were cloned into pCRTM4Blunt-TOPOVR and
sequenced. The sequences of all RACE primers are in
Supporting Information Table S6.
Statistical analyses
Statistical analyses of transcript and precursor transcript
levels using qPCR were carried out using GraphPad Prism
5.0. One-way ANOVA was carried out for each experimen-
tal set to determine overall significance of difference fol-
lowed by Tukey post hoc. Significance of difference for Li-
Cor Western blots was carried out using pairwise t tests.
For all data analyses, differences were considered signifi-
cant with P 0.05.
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